Home
/
Nutex Health Inc.
/
Financials
/
Quarterly
Nutex Health Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Nutex Health Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$267.80M
Nov 19, 2025
Q2
2025
Jun 30, 2025
$243.99M
Nov 18, 2025
Q1
2025
Mar 31, 2025
$211.79M
Nov 18, 2025
Q3
2025
Sep 30, 2024
$78.80M
Nov 19, 2025
Q2
2025
Jun 30, 2024
$76.08M
Nov 18, 2025
Q1
2025
Mar 31, 2024
$67.45M
Nov 18, 2025
Q3
2024
Sep 30, 2023
$62.72M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$58.92M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$56.33M
May 9, 2024
Q3
2023
Sep 30, 2022
$28.40M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$58.05M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$79.13M
May 15, 2023
Q3
2022
Sep 30, 2021
$117.97M
Nov 21, 2022
Q2
2022
Jun 30, 2021
$62.81M
Aug 22, 2022
Q1
2022
Mar 31, 2021
$2.01M
May 13, 2022
Q3
2021
Sep 30, 2020
$350.0K
Nov 15, 2021
Q2
2021
Jun 30, 2020
$378.6K
Aug 16, 2021
Q1
2021
Mar 31, 2020
$465.6K
May 24, 2021
Q3
2020
Sep 30, 2019
$194.6K
Nov 16, 2020
Q2
2020
Jun 30, 2019
$445.3K
Sep 23, 2020
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2022
Sep 30, 2022
$29.00M
Nov 21, 2022
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$4.2K
May 15, 2018
Q3
2017
Sep 30, 2017
$19.0K
Nov 20, 2017
Q2
2017
Jun 30, 2017
$4.6K
Aug 18, 2017
Q1
2018
Mar 31, 2017
$4.4K
May 15, 2018
Q3
2017
Sep 30, 2016
$0
Nov 20, 2017
Q2
2017
Jun 30, 2016
$0
Aug 18, 2017
Q1
2016
Mar 31, 2016
$403.8K
May 23, 2016
Q3
2015
Sep 30, 2015
$312.1K
Nov 16, 2015
Q2
2015
Jun 30, 2015
$347.8K
Aug 18, 2015
Q1
2016
Mar 31, 2015
$300.3K
May 23, 2016
Q3
2015
Sep 30, 2014
$269.2K
Nov 16, 2015
Q2
2015
Jun 30, 2014
$310.4K
Aug 18, 2015
Q1
2015
Mar 31, 2014
$240.2K
May 14, 2015
Q3
2014
Sep 30, 2013
$397.1K
Nov 12, 2014
Q2
2013
Jun 30, 2013
$411.7K
Aug 15, 2013
Q1
2014
Mar 31, 2013
$362.8K
May 14, 2014
Q3
2013
Sep 30, 2012
$416.4K
Nov 13, 2013
Q2
2013
Jun 30, 2012
$429.2K
Aug 15, 2013
Q1
2013
Mar 31, 2012
$480.3K
Jul 23, 2013
Q3
2012
Sep 30, 2011
$410.3K
Nov 14, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$55.44M
Nov 19, 2025
Q2
2025
Jun 30, 2025
($17.70M)
Nov 18, 2025
Q1
2025
Mar 31, 2025
$21.22M
Nov 18, 2025
Q3
2025
Sep 30, 2024
($8.79M)
Nov 19, 2025
Q2
2025
Jun 30, 2024
($364.0K)
Nov 18, 2025
Q1
2025
Mar 31, 2024
($364.0K)
Nov 18, 2025
Q3
2024
Sep 30, 2023
($5.54M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($3.48M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($5.15M)
May 9, 2024
Q3
2023
Sep 30, 2022
($412.19M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($19.28M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
$21.44M
May 15, 2023
Q3
2022
Sep 30, 2021
$74.49M
Nov 21, 2022
Q2
2022
Jun 30, 2021
$29.68M
Aug 22, 2022
Q1
2022
Mar 31, 2021
($4.48M)
May 13, 2022
Q3
2021
Sep 30, 2020
$1.76M
Nov 15, 2021
Q2
2021
Jun 30, 2020
$227.3K
Aug 16, 2021
Q1
2021
Mar 31, 2020
($1.12M)
May 24, 2021
Q3
2020
Sep 30, 2019
($857.6K)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($1.63M)
Sep 23, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$130.37M
Nov 19, 2025
Q2
2025
Jun 30, 2025
$33.68M
Nov 18, 2025
Q1
2025
Mar 31, 2025
$80.66M
Nov 18, 2025
Q3
2025
Sep 30, 2024
$9.66M
Nov 19, 2025
Q2
2025
Jun 30, 2024
$5.30M
Nov 18, 2025
Q1
2025
Mar 31, 2024
$1.45M
Nov 18, 2025
Q3
2024
Sep 30, 2023
($821.2K)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($362.5K)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($4.45M)
May 9, 2024
Q3
2023
Sep 30, 2022
($428.68M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($1.38M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
$29.24M
May 15, 2023
Q3
2022
Sep 30, 2021
$74.46M
Nov 21, 2022
Q2
2022
Jun 30, 2021
$27.60M
Aug 22, 2022
Q1
2022
Mar 31, 2021
($4.15M)
May 13, 2022
Q3
2021
Sep 30, 2020
$1.78M
Nov 15, 2021
Q2
2021
Jun 30, 2020
$645.6K
Aug 16, 2021
Q1
2021
Mar 31, 2020
($939.9K)
May 24, 2021
Q3
2020
Sep 30, 2019
($906.1K)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($1.49M)
Sep 23, 2020